An Extension Study to Investigate the Safety and Durability of Clinical Activity of GS-1101 in Patients with Hematologic Malignancies [EXTENSION OF 700059751]

Trial Profile

An Extension Study to Investigate the Safety and Durability of Clinical Activity of GS-1101 in Patients with Hematologic Malignancies [EXTENSION OF 700059751]

Active, no longer recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 09 Dec 2014

At a glance

  • Drugs Idelalisib (Primary)
  • Indications Chronic lymphocytic leukaemia
  • Focus Adverse reactions
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 11 Jul 2013 M.D. Anderson record 2011-0612 has an incorrect NCT ID (NCT01090414), which matches 2011-1182. They say it should be NCT01659021 and they will correct it (but that also appears to be incorrect)..
    • 11 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top